Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06483659
PHASE2
Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy
Sponsor: Brigham and Women's Hospital
View on ClinicalTrials.gov
Summary
This is a randomized, double-blinded, placebo-controlled trial to compare the effectiveness of IV oxytocin infusion to placebo on peri-operative opioid consumption and reducing post-operative pain following a minimally invasive hysterectomy under general anesthesia.
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
152
Start Date
2025-06-01
Completion Date
2026-12-01
Last Updated
2025-12-30
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Oxytocin
Intravenous Oxytocin infusion
DRUG
Placebo
0.9% Saline
Locations (1)
Brigham and Women's Hospital
Boston, Massachusetts, United States